Published in Cell Death Dis on June 12, 2014
Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway. Oncotarget (2015) 1.62
Long noncoding RNA FER1L4 suppresses cancer cell growth by acting as a competing endogenous RNA and regulating PTEN expression. Sci Rep (2015) 0.97
Noncoding RNA as therapeutic targets for hepatocellular carcinoma. Semin Liver Dis (2015) 0.94
DNMT1-associated long non-coding RNAs regulate global gene expression and DNA methylation in colon cancer. Hum Mol Genet (2015) 0.93
Functional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer. Oncotarget (2016) 0.92
Upregulation of H19 promotes invasion and induces epithelial-to-mesenchymal transition in esophageal cancer. Oncol Lett (2015) 0.92
Hypoxia-inducible factor 1 and breast cancer metastasis. J Zhejiang Univ Sci B (2015) 0.92
ROR functions as a ceRNA to regulate Nanog expression by sponging miR-145 and predicts poor prognosis in pancreatic cancer. Oncotarget (2016) 0.91
Upregulation of H19 indicates a poor prognosis in gallbladder carcinoma and promotes epithelial-mesenchymal transition. Am J Cancer Res (2015) 0.90
Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway. Cancer Sci (2015) 0.89
Expression of the Long Non-Coding RNA HOTAIR Correlates with Disease Progression in Bladder Cancer and Is Contained in Bladder Cancer Patient Urinary Exosomes. PLoS One (2016) 0.89
Long non-coding RNA regulation of epithelial-mesenchymal transition in cancer metastasis. Cell Death Dis (2016) 0.87
The roles of ncRNAs and histone-modifiers in regulating breast cancer stem cells. Protein Cell (2015) 0.87
MicroRNA Regulation of Human Breast Cancer Stem Cells. J Clin Med (2015) 0.84
The role of non-coding RNAs in the regulation of stem cells and progenitors in the normal mammary gland and in breast tumors. Front Genet (2015) 0.83
Nifuroxazide induces apoptosis and impairs pulmonary metastasis in breast cancer model. Cell Death Dis (2015) 0.82
Biological and clinical significance of cancer stem cell plasticity. Clin Transl Med (2014) 0.82
Long non-coding RNAs: potential new biomarkers for predicting tumor invasion and metastasis. Mol Cancer (2016) 0.82
Emerging paradigms of long non-coding RNAs in gastrointestinal cancer. Am J Stem Cells (2014) 0.81
Long non-coding RNA ROR promotes proliferation, migration and chemoresistance of nasopharyngeal carcinoma. Cancer Sci (2016) 0.80
Circular RNA 0000096 affects cell growth and migration in gastric cancer. Br J Cancer (2017) 0.80
Epigenetic regulation of epithelial-mesenchymal transition. Cell Mol Life Sci (2016) 0.79
The long non-coding RNA, SNHG6-003, functions as a competing endogenous RNA to promote the progression of hepatocellular carcinoma. Oncogene (2016) 0.79
The degradation of EZH2 mediated by lncRNA ANCR attenuated the invasion and metastasis of breast cancer. Cell Death Differ (2016) 0.79
Roles of long non-coding RNAs in gastric cancer metastasis. World J Gastroenterol (2015) 0.79
AUF1 regulation of coding and noncoding RNA. Wiley Interdiscip Rev RNA (2016) 0.78
Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells. Cancers (Basel) (2017) 0.78
The crosstalk between lncRNA and microRNA in cancer metastasis: orchestrating the epithelial-mesenchymal plasticity. Oncotarget (2016) 0.78
CTRL+INSERT: retrotransposons and their contribution to regulation and innovation of the transcriptome. EMBO Rep (2016) 0.77
Prognostic value of long non-coding RNA CCAT1 expression in patients with cancer: A meta-analysis. PLoS One (2017) 0.76
Transcriptome-wide identification of mRNAs and lincRNAs associated with trastuzumab-resistance in HER2-positive breast cancer. Oncotarget (2016) 0.76
circRNA_100290 plays a role in oral cancer by functioning as a sponge of the miR-29 family. Oncogene (2017) 0.76
The dual function of PRMT1 in modulating epithelial-mesenchymal transition and cellular senescence in breast cancer cells through regulation of ZEB1. Sci Rep (2016) 0.75
Long Non-Coding RNA Reprogramming (ROR) Promotes Cell Proliferation in Colorectal Cancer via Affecting P53. Med Sci Monit (2017) 0.75
3,6-dihydroxyflavone suppresses the epithelial-mesenchymal transition in breast cancer cells by inhibiting the Notch signaling pathway. Sci Rep (2016) 0.75
Sinomenine hydrochloride inhibits breast cancer metastasis by attenuating inflammation-related epithelial-mesenchymal transition and cancer stemness. Oncotarget (2017) 0.75
Uncovering the roles of long non-coding RNAs in cancer stem cells. J Hematol Oncol (2017) 0.75
LncRNAs: From Basic Research to Medical Application. Int J Biol Sci (2017) 0.75
Viruses, stemness, embryogenesis, and cancer: a miracle leap toward molecular definition of novel oncotargets for therapy-resistant malignant tumors? Oncoscience (2015) 0.75
Linc-ROR and its spliced variants 2 and 4 are significantly up-regulated in esophageal squamous cell carcinoma. Iran J Basic Med Sci (2016) 0.75
Large intergenic non-coding RNA-ROR reverses gemcitabine-induced autophagy and apoptosis in breast cancer cells. Oncotarget (2016) 0.75
Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor Therapy. Cancer Res (2016) 0.75
Roles of Long Noncoding RNAs in Recurrence and Metastasis of Radiotherapy-Resistant Cancer Stem Cells. Int J Mol Sci (2017) 0.75
Insights from Global Analyses of Long Noncoding RNAs in Breast Cancer. Curr Pathobiol Rep (2017) 0.75
PTENP1 acts as a ceRNA to regulate PTEN by sponging miR-19b and explores the biological role of PTENP1 in breast cancer. Cancer Gene Ther (2017) 0.75
Endogenous miRNA Sponge LincRNA-ROR promotes proliferation, invasion and stem cell-like phenotype of pancreatic cancer cells. Cell Death Discov (2017) 0.75
Ionizing radiation regulates long non-coding RNAs in human peripheral blood mononuclear cells. J Radiat Res (2016) 0.75
Long non-coding RNAs as novel biomarkers for breast cancer invasion and metastasis. Oncol Lett (2017) 0.75
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16
Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A (2003) 59.17
The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell (2008) 46.08
Epithelial-mesenchymal transitions in development and disease. Cell (2009) 39.17
Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature (2009) 35.48
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell (2004) 31.38
The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol (2008) 24.27
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature (2010) 23.55
Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer (2007) 18.69
Evolution and functions of long noncoding RNAs. Cell (2009) 17.54
Long noncoding RNA as modular scaffold of histone modification complexes. Science (2010) 15.23
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev (2008) 15.01
let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell (2007) 13.69
Molecular mechanisms of long noncoding RNAs. Mol Cell (2011) 11.44
lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature (2011) 11.31
Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol (2003) 11.12
A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell (2011) 9.24
The Air noncoding RNA epigenetically silences transcription by targeting G9a to chromatin. Science (2008) 8.45
Long noncoding RNAs and human disease. Trends Cell Biol (2011) 7.59
Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nat Genet (2010) 5.37
Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc Natl Acad Sci U S A (2007) 5.24
CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells. Breast Cancer Res (2005) 4.79
Systematic identification of long noncoding RNAs expressed during zebrafish embryogenesis. Genome Res (2011) 3.81
The H19 non-coding RNA is essential for human tumor growth. PLoS One (2007) 3.75
Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol (2004) 3.64
Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA. Genes Dev (2010) 3.49
miRNP:mRNA association in polyribosomes in a human neuronal cell line. RNA (2004) 3.39
The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell (2013) 3.27
Cancer trends in China. Jpn J Clin Oncol (2010) 3.06
Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal. Dev Cell (2013) 2.77
Transitions between epithelial and mesenchymal states in development and disease. Semin Cell Dev Biol (2008) 2.69
Suppression of cell growth and invasion by miR-205 in breast cancer. Cell Res (2009) 2.65
Human long non-coding RNAs promote pluripotency and neuronal differentiation by association with chromatin modifiers and transcription factors. EMBO J (2011) 2.51
Retracted HMGA2 functions as a competing endogenous RNA to promote lung cancer progression. Nature (2013) 2.47
EMT and stem cell-like properties associated with miR-205 and miR-200 epigenetic silencing are early manifestations during carcinogen-induced transformation of human lung epithelial cells. Cancer Res (2011) 2.32
The H19 locus: role of an imprinted non-coding RNA in growth and development. Bioessays (2010) 2.23
Epithelial-mesenchymal transitions: a mesodermal cell strategy for evolutive innovation in Metazoans. Anat Rec (2002) 2.01
Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation. Oncogene (2012) 1.95
Discrimination of non-protein-coding transcripts from protein-coding mRNA. RNA Biol (2006) 1.82
A nucleolar protein, H19 opposite tumor suppressor (HOTS), is a tumor growth inhibitor encoded by a human imprinted H19 antisense transcript. Proc Natl Acad Sci U S A (2011) 1.77
Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro. Oncogene (2007) 1.77
Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells. Carcinogenesis (2002) 1.69
The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage. Cell Res (2012) 1.66
MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1. Oncogene (2012) 1.54
MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1. Clin Exp Med (2012) 1.49
SOX2 expression associates with stem cell state in human ovarian carcinoma. Cancer Res (2013) 1.34
Upregulated H19 contributes to bladder cancer cell proliferation by regulating ID2 expression. FEBS J (2013) 1.26
Modulation of hypoxia-signaling pathways by extracellular linc-RoR. J Cell Sci (2014) 1.09
Elucidating the temporal order of silencing. EMBO Rep (2012) 0.99
Involvement of polypyrimidine tract-binding protein (PTBP1) in maintaining breast cancer cell growth and malignant properties. Oncogenesis (2014) 0.93
PTBP1-dependent regulation of USP5 alternative RNA splicing plays a role in glioblastoma tumorigenesis. Mol Carcinog (2011) 0.92
Retracted Polypyrimidine tract-binding protein regulates the cell cycle through IRES-dependent translation of CDK11(p58) in mouse embryonic stem cells. Cell Cycle (2011) 0.90